Nonetheless, further studies are needed to elucidate the molecular mechanisms by which the DVL3 participates in the development and progression of HCC, and to address whether the DVL3 could be used as a target for novel therapeutic approaches. The gene discussed is DVL3; the disease is hepatocellular carcinoma.